3 completed, 3 recruiting, 1 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 3, Recruiting 3, Withdrawn 1 |
Follow Developmental Disabilities: new trials by email Literature Review of Developmental Disabilities trials Research Report on Developmental Disabilities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities Deutetrabenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability | Phase 4 | Recruiting | University Hospitals Cleveland Medical Center | 25 | 2026-06-22 | 2026-07-06 |
| Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities Valbenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability | Phase 4 | Withdrawn | Stephen Ruedrich | 2025-01-01 | 2024-10-24 | |
| Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability Metformin, Placebo, Lifestyle Intervention - Intellectual Disability, Developmental Disability | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 100 | 2023-02-28 | 2026-03-31 |
| Use of Hyperpolarized 129Xe MR Lung Imaging in Infants 129Xe - Lungs; Developmental Disorder | Phase 4 | Recruiting | Children's Hospital Medical Center, Cincinnati | 12 | 2020-05-06 | 2026-01-07 |
| Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population Swallow instruction - Epilepsy, Mental Retardation | Phase 4 | Completed | Children's National Research Institute | 20 | 2005-08-01 | 2008-05-05 |
| Vanderbilt University Spasticity Management Program Evaluation Plan Botulinum Toxin Type A, Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB) - Spasticity | Phase 4 | Completed | Vanderbilt University | 20 | 2002-08-01 | 2007-08-20 |
| Methylphenidate Study in Young Children With Developmental Disorders Methylphenidate - Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | University of Arizona | 48 | 2001-05-01 | 2012-07-04 |
Intellectual Disability (4) · Caregiver Burden (2) · Movement Disorders (2) · Tardive Dyskinesia (2) · Attention Deficit Disorder with Hyperactivity (1) · Epilepsy (1) · Learning Disabilities (1) · Muscle Spasticity (1) · Obesity (1) · Seizures (1)
Mental Disorders (7) · Neurodevelopmental Disorders (7) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Neurobehavioral Manifestations (4) · Central Nervous System Diseases (3) · Behavior (2) · Behavioral Symptoms (2) · Dyskinesia, Drug-Induced (2) · Dyskinesias (2) · Stress, Psychological (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Body Weight (1)
Botulinum Toxins, Type A (1) · Metformin (1) · Methylphenidate (1) · deutetrabenazine (1) · valbenazine (1)
Centre for Addiction and Mental Health (1) · Children's Hospital Medical Center, Cincinnati (1) · Children's National Research Institute (1) · Stephen Ruedrich (1) · University Hospitals Cleveland Medical Center (1) · University of Arizona (1) · Vanderbilt University (1)
United States (5) · Canada (1)
Stephen Ruedrich, MD (2) · David Charles, MD (1) · Jason Woods, PhD (1) · Jaswinder K Ghuman, M.D. (1) · Joan A Conry, MD (1)